461 related articles for article (PubMed ID: 33131450)
1. Delayed hypersensitivity to oxaliplatin in a nigerian patient with colorectal cancer-A case report.
Aliyu UM; Okwonna CO
J Oncol Pharm Pract; 2021 Jul; 27(5):1258-1260. PubMed ID: 33131450
[TBL] [Abstract][Full Text] [Related]
2. Successful oxaliplatin desensitization protocol in a patient with colorectal metastatic cancer.
de Lira-Quezada CE; Villarreal-Gonzalez RV; Gonzalez-Diaz SN; Carrasco-Diaz LL
J Oncol Pharm Pract; 2021 Mar; 27(2):490-493. PubMed ID: 32635810
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity reactions to oxaliplatin in two asian patients.
Ng CV
Ann Pharmacother; 2005 Jun; 39(6):1114-8. PubMed ID: 15886290
[TBL] [Abstract][Full Text] [Related]
4. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
Nozawa H; Muto Y; Yamada Y
Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
Hewitt MR; Sun W
Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity reactions to oxaliplatin: experience in a single institute.
Siu SW; Chan RT; Au GK
Ann Oncol; 2006 Feb; 17(2):259-61. PubMed ID: 16282245
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches.
Bano N; Najam R; Qazi F; Mateen A
Asian Pac J Cancer Prev; 2016; 17(4):1637-41. PubMed ID: 27221832
[TBL] [Abstract][Full Text] [Related]
8. Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening.
Vyskocil J; Tucek S; Kiss I; Fedorova L; Nevrlka J; Zdrazilova-Dubska L
Int Immunopharmacol; 2019 Sep; 74():105728. PubMed ID: 31288153
[TBL] [Abstract][Full Text] [Related]
9. Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?
Elligers KT; Davies M; Sanchis D; Ferencz T; Saif MW
JOP; 2008 Mar; 9(2):197-202. PubMed ID: 18326929
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin immune-mediated thrombocytopenia: Is there a role for premedication or desensitization?
Gal S; Noa M; Ofer M; Naama H; Ben B; Einat SS
Br J Clin Pharmacol; 2022 Feb; 88(2):842-845. PubMed ID: 34237795
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.
Bautista MA; Stevens WT; Chen CS; Curtis BR; Aster RH; Hsueh CT
J Hematol Oncol; 2010 Mar; 3():12. PubMed ID: 20346128
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
Thomas RR; Quinn MG; Schuler B; Grem JL
Cancer; 2003 May; 97(9):2301-7. PubMed ID: 12712487
[TBL] [Abstract][Full Text] [Related]
14. Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.
Saif M; Roy S; Ledbetter L; Madison J; Syrigos K
World J Gastroenterol; 2007 Oct; 13(39):5277-81. PubMed ID: 17876901
[TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of a rechallenge protocol in patients experiencing hypersensitivity reactions with prior chemotherapy in a tertiary hospital.
Wu HL
J Oncol Pharm Pract; 2019 Sep; 25(6):1388-1395. PubMed ID: 30176784
[TBL] [Abstract][Full Text] [Related]
16. Management and preparedness for infusion and hypersensitivity reactions.
Lenz HJ
Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of a Dexamethasone Dose Escalation Regimen with a Cumulative Dose for Preventing Oxaliplatin Hypersensitivity Reactions].
Morii Y; Senaha H; Matsui S; Okawa K; Tsubaki M; Matzno S; Shimomura K; Nishida S
Gan To Kagaku Ryoho; 2022 Jul; 49(7):769-773. PubMed ID: 35851348
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features of Oxaliplatin-induced Hypersensitivity Reactions in Chinese Patients: A Retrospective Multicenter Analysis.
Li M; Jiang C; Yang JW; Yu ZQ; Li W; Zhao L; Song QY; Zhang CL; Liu D
Curr Med Sci; 2021 Aug; 41(4):827-831. PubMed ID: 34403109
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of reintroducing oxaliplatin to patients with colorectal cancer after mild hypersensitivity reactions.
Park SJ; Lee KY; Park WS; Min SY
Oncology; 2013; 85(6):323-7. PubMed ID: 24247529
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
